Flex Pharma IPO Research Information

Flex Pharma IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Flex Pharma, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Flex Pharma	FLKS - NASDAQ	$12.00-$14.00	$16.00	$19.00	5.4 million	1/29/2015
Underwriter(s): Jefferies, Piper Jaffray
Co-Manager(s): JMP Securities, Cantor Fitzgerald, Roth Capital Partners
Industry: Health Care
Filing(s): Filed 2014-12-29 Terms Added 2015-01-20

Flex Pharma Quote & Chart - Click for current quote - FLKS

About Flex Pharma (adapted from Flex Pharma prospectus):
They are a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "FLKS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.